Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Svetlana, Kovel"'
Autor:
Avishay Sella, Svetlana Kovel
Publikováno v:
International Brazilian Journal of Urology, Vol 38, Iss 1, Pp 49-56 (2012)
PURPOSE: Combination of gemcitabine and carboplatin is the accepted treatment for metastatic urothelial cancer patients unfit for cisplatin-based chemotherapy. MATERIALS AND METHODS: Gemcitabine 1000 mg/m² (days 1, 8) and carboplatin AUC-4.5 (day 1)
Externí odkaz:
https://doaj.org/article/e946d1e4ced44ae986a312fc45160a93
Autor:
Svetlana Kovel, Misgav Rottenstreich, Noam Smorgick, Zvi Vaknin, Ilan Wassermann, Anca Mihailovici
Publikováno v:
Medicine. 96:e9136
Background:Endometriosis-associated malignant transformation in abdominal surgical scar (EAMTAS) is a very rare and aggressive phenomenon. Our current article aims to provide a clinical overview, focusing on risk factors affecting survival.Methods:We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12f208164b4967986645911202034e3f
https://doi.org/10.1097/md.0000000000009136
https://doi.org/10.1097/md.0000000000009136
Publikováno v:
Journal of Clinical Oncology. 35:e16561-e16561
e16561 Background: CT-PET PSMA has recently been approved to more accurately detect the extent of prostate cancer. Here we examined PSA level and kinetics (PSA doubling time-PSADT) as a predictor of positive up-take in patients evaluated for suspecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92f830fda3c63e2534b0dc05d6131506
https://doi.org/10.1200/jco.2017.35.15_suppl.e16561
https://doi.org/10.1200/jco.2017.35.15_suppl.e16561
Autor:
Dana, Livne-Segev, Maya, Gottfried, Natalie, Maimon, Avivit, Peer, Avivit, Neumann, Henry, Hayat, Svetlana, Kovel, Avishay, Sella, Wilmosh, Mermershtain, Keren, Rouvinov, Ben, Boursi, Rony, Weitzen, Raanan, Berger, Daniel, Keizman
Publikováno v:
The Israel Medical Association journal : IMAJ. 16(6)
The VEGFR/PDGFR inhibitor sunitinib was approved in Israel in 2008 for the treatment of metastatic renal cell carcinoma (mRCC), based on an international trial. However, the efficacy of sunitinib treatment in Israeli mRCC patients has not been previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cfc16e7b9f9ba3fc858bc8f94e6e6f51
https://pubmed.ncbi.nlm.nih.gov/25058995
https://pubmed.ncbi.nlm.nih.gov/25058995
Autor:
Daniel Keizman, Avishay Sella, Avivit Peer, Henry Hayat, Stephen Jay Frank, Tal Sella, David Sharide, Ekaterina Hanovich, Raanan Berger, Eli Gez, Victoria Neiman, Eli Rosenbaum, Svetlana Kovel
Publikováno v:
Clinical genitourinary cancer. 12(6)
Background Cabazitaxel and AA have been approved by the US Food and Drug Administration for use after docetaxel in mCRPC. Recently, CAB appeared to be active when given after AA. AA is capable of inducing AR splice variants that confer ligand-indepen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad1e247c619ac8ce828e8afde08a6b8
https://pubmed.ncbi.nlm.nih.gov/25066221
https://pubmed.ncbi.nlm.nih.gov/25066221
Autor:
Michael A. Carducci, Maya Ish-Shalom, Rony Weitzen, Roberto Pili, Daniel Keizman, Natalie Maimon, Maya Gottfried, Avivit Neumann, Hans J. Hammers, Avivit Peer, Ben Boursi, Wilmosh Mermershtain, Henry Hayat, Mario A. Eisenberger, Victoria J. Sinibaldi, Keren Rouvinov, Raanan Berger, Avishay Sella, Svetlana Kovel
Publikováno v:
The oncologist. 19(1)
Obesity, smoking, hypertension, and diabetes are risk factors for renal cell carcinoma development. Their presence has been associated with a worse outcome in various cancers. We sought to determine their association with outcome of sunitinib treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15f8d265831c2025018f09fd189120b
https://pubmed.ncbi.nlm.nih.gov/24309979
https://pubmed.ncbi.nlm.nih.gov/24309979
Autor:
Ronen M, Brenner, Shaye, Kivity, Yulia, Kundel, Ofer, Purim, Nir, Peled, Efraim, Idelevich, Konstantin, Lavrenkov, Svetlana, Kovel, Eyal, Fenig, Aaron, Sulkes, Baruch, Brenner
Publikováno v:
Anticancer research. 33(11)
Data on differences in toxicity and efficacy of chemotherapy and radiotherapy among different ethnic groups is limited. We evaluated differences in toxicity, tolerability and clinical outcome of Ashkenazi and non-Ashkenazi Jews receiving postoperativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85dbb54b20171e5730d3942f745c27a9
https://pubmed.ncbi.nlm.nih.gov/24222163
https://pubmed.ncbi.nlm.nih.gov/24222163
Autor:
V. J. Sinibaldi, Maya Gottfried, Hans J. Hammers, V. Neiman, Svetlana Kovel, Daniel Keizman, Avivit Neumann, Mario A. Eisenberger, Michael A. Carducci, Eliahu Gez, Raanan Berger, Avivit Peer, Wilmosh Mermershtain, Ariel Hammerman, Nimrod Maimon, Eli Rosenbaum, Avishay Sella, Keren Rouvinov, David Sarid, Ilan Feldhamer
Publikováno v:
European Urology Supplements. 15:e1740
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd6fe359ca419dc5419437ba30f3ee9a
https://doi.org/10.1016/s1569-9056(16)30500-0
https://doi.org/10.1016/s1569-9056(16)30500-0
Autor:
Eli Rosenbaum, Igal Kushnir, Eliahu Gez, Mario A. Eisenberger, Raanan Berger, Avivit Neumann, Wilmosh Mermershtain, Keren Rouvinov, V. J. Sinibaldi, Svetlana Kovel, Nimrod Maimon, Maya Gottfried, David Sarid, Michael A. Carducci, Avivit Peer, Avishay Sella, V. Neiman, Hans J. Hammers, Daniel Keizman
Publikováno v:
European Urology Supplements. 15:e1741
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ffd9a18f9244b4da04400ba10fb1252
https://doi.org/10.1016/s1569-9056(16)30501-2
https://doi.org/10.1016/s1569-9056(16)30501-2
Autor:
Avivit Peer, Avivit Neumann, Avishay Sella, Eli Rosenbaum, Victoria Neiman, Maya Gottfried, Svetlana Kovel, David Sarid, Eli Gez, Wilmosh Mermershtain, Keren Rouvinov, Michael Anthony Carducci, Mario A. Eisenberger, Victoria J. Sinibaldi, Raanan Berger, Daniel Keizman
Publikováno v:
Journal of Clinical Oncology. 34:e16535-e16535
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c6430ea585034c17edfb6427a4620e6
https://doi.org/10.1200/jco.2016.34.15_suppl.e16535
https://doi.org/10.1200/jco.2016.34.15_suppl.e16535